Use of White Granulated Sugar on Wounds

NCT ID: NCT01716273

Last Updated: 2012-10-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

108 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-06-30

Study Completion Date

2014-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

How effective is sugar in reducing the debriding of sloughy, necrotic or infected exudating wounds compared with standard treatment?

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients for whom all the following apply:

Have an exudating wound sizes 5cm2 and 40cm2 A minimum of 25% slough, infected and necrotic tissue No dry necrotic eschar present Ankle Brachial Pressure Index of greater than 0.6 Are over 18 years Independently and willingly consent

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Infected Wounds

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Chronic & Acute infected wounds

Wound will be cleaned with normal saline or tap water and Granulated sugar will be applied directly to the wound and covered with an absorbent pad and held in place with a bandage and tape.

Group Type EXPERIMENTAL

Granulated Sugar

Intervention Type OTHER

30 grams of granulated sugar is used to cover the wound area and this is held in place using a dry dressing pad , bandage and tape.

Debridement Dressing

Intervention Type OTHER

1 Aquacel or Sorbsan dressing will be put over the wound, and held in place with a dry dressing pad, bandage and tape.

Chronic and Acute infected wounds

Wound will be cleaned with normal saline or tap water and an appropriate debridement dressing (Aquacel or Sorbsan) is applied to the wound and secured with a bandage and surgical tape.

Group Type ACTIVE_COMPARATOR

Granulated Sugar

Intervention Type OTHER

30 grams of granulated sugar is used to cover the wound area and this is held in place using a dry dressing pad , bandage and tape.

Debridement Dressing

Intervention Type OTHER

1 Aquacel or Sorbsan dressing will be put over the wound, and held in place with a dry dressing pad, bandage and tape.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Granulated Sugar

30 grams of granulated sugar is used to cover the wound area and this is held in place using a dry dressing pad , bandage and tape.

Intervention Type OTHER

Debridement Dressing

1 Aquacel or Sorbsan dressing will be put over the wound, and held in place with a dry dressing pad, bandage and tape.

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Sucrose Aquacel or Sorbsan

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Exudating wound sizes 5cm2 and 40cm2
* A minimum of 25% slough, infected and necrotic tissue
* No dry necrotic eschar
* Ankle Brachial Pressure Index of greater than 0.6
* Age over 18 years
* Able to independently and willingly consent

Exclusion Criteria

* Participants in a trial evaluating other therapies for their wound
* Have previously been in this trial
* Women who are pregnant
* Participants not able to tolerate daily dressing change
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Laboratoires URGO

INDUSTRY

Sponsor Role collaborator

University of Wolverhampton

OTHER

Sponsor Role collaborator

University of Birmingham

OTHER

Sponsor Role collaborator

Moses Murandu

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Moses Murandu

PhD student

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Malcolm Simms, MBBSFRCS

Role: PRINCIPAL_INVESTIGATOR

University Hospital Birmingham NHS Fondation Trust

Moses Murandu, PhD student

Role: STUDY_DIRECTOR

University of Wolverhampton

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Hospital Birmingham NHS Foundation Trust

Birmingham, West Midlands, United Kingdom

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Moses Murandu, PhD student

Role: CONTACT

Phone: 07743025072

Email: [email protected]

Malcolm Simms, MBBSFRCS

Role: CONTACT

Phone: 07768147025

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Rachel Hornabrook

Role: primary

Carol Dealey, PhD

Role: backup

References

Explore related publications, articles, or registry entries linked to this study.

Murandu M, Webber MA, Simms MH, Dealey C. Use of granulated sugar therapy in the management of sloughy or necrotic wounds: a pilot study. J Wound Care. 2011 May;20(5):206, 208, 210 passim. doi: 10.12968/jowc.2011.20.5.206.

Reference Type BACKGROUND
PMID: 21647066 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RRK4106

Identifier Type: -

Identifier Source: org_study_id